About Eagle Genomics
Eagle Genomics is a company based in Cambridge (United Kingdom) founded in 2008. Eagle Genomics has raised $38.73 million across 9 funding rounds from investors including Gov.uk, Newable and abrdn. Eagle Genomics offers products and services including e[datascientist], e[exploration], e[biology], e[datascience], and e[sdk]. Eagle Genomics operates in a competitive market with competitors including DNAnexus, Genomics, Depixus, Seven Bridges Genomics and Ingenuity Systems, among others.
- Headquarter Cambridge, United Kingdom
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Eagle Genomics Limited
- Date of Incorporation 07 May, 2008
- Jurisdiction CAMBRIDGE, CAMBRIDGESHIRE, ENGLAND
-
Annual Revenue
$3.35 M (USD)79as on Mar 31, 2022
-
Net Profit
-$6.88 M (USD)-101as on Mar 31, 2022
-
EBITDA
-$6.88 M (USD)-101as on Mar 31, 2022
-
Total Equity Funding
$38.73 M (USD)
in 9 rounds
-
Latest Funding Round
$3.65 M (USD), Series C
Sep 27, 2023
-
Investors
Gov.uk
& 11 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Eagle Genomics
Eagle Genomics offers a comprehensive portfolio of products and services, including e[datascientist], e[exploration], e[biology], e[datascience], and e[sdk].
Platform for analyzing microbiome data to drive innovation.
Tool for exploring complex microbiome patterns and relationships.
Service for biological data integration in microbiome research.
Application for advanced data science in microbiome contexts.
Kit for developing custom microbiome data applications.
Platform for sharing and accessing microbiome data resources.
Tool for detailed reporting on microbial strains and networks.
People of Eagle Genomics
Unlock access to complete
Unlock access to complete
Funding Insights of Eagle Genomics
Eagle Genomics has successfully raised a total of $38.73M across 9 strategic funding rounds. The most recent funding activity was a Series C round of $3.65 million completed in September 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Eagle Genomics
Eagle Genomics has secured backing from 12 investors, including venture fund, angel, and institutional investors. Prominent investors backing the company include Gov.uk, Newable and abrdn.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Early-stage investments in tech and energy sectors are targeted.
|
Locked | Locked | Locked | |
|
Granpool is recognized as a venture capital investment firm.
|
Locked | Locked | Locked | |
|
Multiple sectors are invested in by abrdn's private equity fund.
|
Locked | Locked | Locked |
Investor details for Eagle Genomics
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Eagle Genomics
Investment portfolio details for Eagle Genomics
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Eagle Genomics
Detailed financials for Eagle Genomics
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Eagle Genomics Comparisons
Peer comparison for Eagle Genomics
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Eagle Genomics
Eagle Genomics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as DNAnexus, Genomics, Depixus, Seven Bridges Genomics and Ingenuity Systems, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Cloud-based genome informatics and data management are provided.
|
|
| Locked | Locked | Locked |
Genomic risk assessment and prevention platform is provided.
|
|
| Locked | Locked | Locked |
Single-molecule genetic and epigenetic sequencing solutions are provided.
|
|
| Locked | Locked | Locked |
Cloud-based platform to analyze, store, and act on genomic data.
|
|
| Locked | Locked | Locked |
Genomic data is analyzed and interpreted via web-based applications.
|
Detailed competitors of Eagle Genomics
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Eagle Genomics
Complete news archive for Eagle Genomics
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Eagle Genomics
Eagle Genomics was founded in 2008 and raised its 1st funding round 5 years after it was founded.
Eagle Genomics is headquartered in Cambridge, United Kingdom. It is registered at Cambridge, Cambridgeshire, United Kingdom.
Anthony Finbow is the current CEO of Eagle Genomics.
Eagle Genomics is a funded company, having raised a total of $38.73M across 9 funding rounds to date.
Annual revenue of Eagle Genomics is $3.35M as on Mar 31, 2022.
Eagle Genomics was founded in 2008 and is based in Cambridge, United Kingdom. Cloud-based software solutions for genomic analysis are provided by the company within the biotechnology sector. Operations focus on platforms such as Eaglecore, which supports collaborative information management in research and development, and EagleEnsembl, which enables searching and analysis of genomic data. Services are delivered through a domain at eaglegenomics.com.
Eagle Genomics's top competitors include DNAnexus, Depixus and Ingenuity Systems.
Eagle Genomics offers e[datascientist], e[exploration], e[biology], e[datascience], and 3 more products and services.
Eagle Genomics has 12 investors. Key investors include Gov.uk, Newable, abrdn, ETF Partners, and Granpool.